View Older Stories View More Recent Stories

Dec 4, 2025 04:38PM After-hours movers: HPE, Ulta Beauty, SoFi, Rubrik and more
Dec 4, 2025 04:12PM Praxis stops EMBOLD study early after relutrigine shows efficacy
Dec 4, 2025 04:01PM Praxis receives FDA alignment on ulixacaltamide NDA submission plans
Nov 24, 2025 09:06AM TD Cowen on Praxis Precision Medicines Inc. (PRAX): 'Sensitivity Analyses Robust & Supportive Of Topline'
Nov 20, 2025 10:49AM Praxis Precision Medicines (PRAX) Mentioned as Short at Culper Research
Nov 6, 2025 01:11PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $540 at Guggenheim
Nov 5, 2025 08:05AM Praxis Precision Medicines (PRAX) Tops Q3 EPS by 11c
Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
Oct 16, 2025 12:52PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $250 at Oppenheimer
Oct 16, 2025 12:31PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $360 at Truist Securities
Oct 16, 2025 12:28PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $275 at Baird
Oct 16, 2025 12:25PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $251 at TD Cowen as Ph3 ET Ulixa Studies Meet Primary
Oct 16, 2025 10:34AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $350 at Guggenheim
Oct 2, 2025 08:08AM Piper Sandler Sees a 'Lucrative Buying Opportunity Ahead' for Praxis Precision Medicines (PRAX)
Sep 17, 2025 04:26PM Jones Trading Starts Praxis Precision Medicines Inc. (PRAX) at Buy
Sep 17, 2025 07:30AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
Aug 11, 2025 08:25AM Piper Sandler Reiterates OW Rating on Praxis Precision Medicines Inc. (PRAX)
Aug 5, 2025 07:37AM Truist Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Aug 5, 2025 06:43AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $115 at H.C. Wainwright
Aug 4, 2025 02:10PM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Aug 4, 2025 01:24PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $33 at Wedbush
Aug 4, 2025 12:58PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $155 at Guggenheim
Aug 4, 2025 09:05AM Praxis Precision Medicines (PRAX) Misses Q2 EPS by 6c
Aug 4, 2025 08:10AM Praxis reports positive seizure reduction results from vormatrigine trial
Jul 18, 2025 06:55AM H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Jul 17, 2025 08:01AM Praxis receives FDA breakthrough therapy designation for relutrigine
Jul 10, 2025 09:45AM Piper Sandler Reiterates OW Rating on Praxis Precision Medicines (PRAX) Post NYC Investor Dinner
Jun 2, 2025 08:55AM Oppenheimer Assumes Praxis Precision Medicines Inc. (PRAX) at Outperform
May 12, 2025 07:58AM Piper Sandler: 'We Remain Bullish on Praxis Precision Medicines Inc. (PRAX)'
May 7, 2025 04:30AM Chardan Capital Markets Starts Praxis Precision Medicines Inc. (PRAX) at Buy
May 5, 2025 08:07AM Praxis Precision Medicines (PRAX) Highlights DEE Clinical Program Updates at Virtual Investor Event
May 5, 2025 05:18AM Guggenheim on Praxis Precision Medicines Inc. (PRAX): 'remains one of our Top Picks for 2025'
May 2, 2025 04:26PM Praxis Precision Medicines (PRAX) Misses Q1 EPS by 42c
Mar 4, 2025 05:00PM Praxis Precision Medicines (PRAX) announces inducement grants
Feb 28, 2025 03:02PM Praxis Precision Medicines Inc. (PRAX) PT Lowered to $61 at TD Cowen
Feb 28, 2025 11:08AM Praxis Precision Medicines Inc. (PRAX) PT Lowered to $85 at Truist Securities
Feb 28, 2025 08:01AM Praxis Precision Medicines (PRAX) IDMC has recommended Essential3 study be stopped for futility
Feb 11, 2025 04:16AM Deutsche Bank Starts Praxis Precision Medicines Inc. (PRAX) at Buy
Jan 22, 2025 11:34AM Jefferies Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Jan 21, 2025 10:56AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $175 at Truist; 'Incrementally Positive On Ph3 ESSENTIAL3'
Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
Dec 23, 2024 04:19PM Praxis Precision Medicines (PRAX) Files Mixed Shelf
Dec 11, 2024 07:38AM Piper Sandler on Praxis Precision Medicines Inc. (PRAX): '2025 a Key Year to Drive Substantial Shares Gains'
Dec 11, 2024 06:12AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $305 at Jefferies
Nov 12, 2024 07:25AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
Nov 6, 2024 03:02PM Guggenheim Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Nov 6, 2024 07:35AM Praxis Precision Medicines (PRAX) Misses Q3 EPS by 76c
Oct 14, 2024 02:35PM Oppenheimer Reiterates Outperform Rating on Praxis Precision Medicines Inc. (PRAX)
Oct 7, 2024 07:14AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
View More Recent Stories View Older Stories